Vitro Biopharma, Inc. Quarterly Operating Lease, Payments in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Vitro Biopharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q4 2021 to Q4 2023.
  • Vitro Biopharma, Inc. Operating Lease, Payments for the quarter ending January 31, 2024 was $56.9K, a 11.1% increase year-over-year.
  • Vitro Biopharma, Inc. annual Operating Lease, Payments for 2023 was $134K, a 8.31% decline from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $56.9K +$5.69K +11.1% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-14
Q4 2022 $51.3K +$31.9K +165% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-14
Q4 2021 $19.4K Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.